rrd278091_313939.html

0001181431-11-026541.txt : 20110503 0001181431-11-026541.hdr.sgml : 20110503 20110503130832 ACCESSION NUMBER: 0001181431-11-026541 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110430 FILED AS OF DATE: 20110503 DATE AS OF CHANGE: 20110503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CROWLEY Richard CENTRAL INDEX KEY: 0001352961 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 11804114 MAIL ADDRESS: STREET 1: IMCLONE SYSTEMS INCORPORATED STREET 2: 180 VARICK STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 3 1 rrd310105.xml CROWLEY FORM 3 X0203 3 2011-04-30 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001352961 CROWLEY Richard SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER BLVD. EAST BRUNSWICK NJ 08816 0 1 0 0 EVP Biopharmaceutical Operatio Common Stock, $.01 par value per share 100000 D Option to Purchase Common Stock, $.01 par value 11.62 2012-04-30 2021-04-30 Common Stock, $.01 par value per share 50000 D The right to receive these shares is pursuant to a restricted stock grant that vests as follows: 25,000 on April 30, 2012, and 6,250 shares at the end of each successive three-month period until April 30, 2015, provided that the grantee remains employed by the Company on these dates. These options will become exercisable as follows: 12,500 on April 30, 2012, and 3,125 shares at the end of each successive three-month period until April 30, 2015, provided the optionee remains employed by the Company on these dates. /s/ Irina Azer Ishak for Richard Crowley 2011-05-03 EX-24.1 2 rrd278091_313939.htm POWER OF ATTORNEY rrd278091_313939.html

POWER OF ATTORNEY
       Know all by these presents, that the undersigned hereby constitutes and appoints each of
Philip K. Yachmetz, Esq. and Irina Azer Ishak, signing singly, the undersigned's true and lawful
attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity as
an officer and/or director of Savient Pharmaceuticals, Inc. (the "Company"),
Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange
Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, or
5, complete and execute any amendment or amendments thereto, and timely file
such form with the United States Securities and Exchange Commission and any
stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the foregoing
which, in the opinion of such attorney-in-fact, may be of benefit to, in the best
interest of, or legally required by, the undersigned, it being understood that the
documents executed by such attorney-in-fact on behalf of the undersigned
pursuant to this Power of Attorney shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in such attorney-in-
fact's discretion.
        The undersigned hereby grants to each such attorney-in-fact full power and authority to
do and perform any and every act and thing whatsoever requisite, necessary, or proper to be
done in the exercise of any of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this
power of attorney and the rights and powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned,
are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934.
       This Power of Attorney shall remain in full force and effect until the undersigned is no
longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.
       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 3rd day of May, 2011.
/s/ Richard Crowley
Signature
Richard Crowley
Print Name